Holen Sie sich die Stockscreener-App
16.76
2.50%
-0.43
Handel nachbörslich:
16.96
0.20
+1.19%
Schlusskurs vom Vortag:
$17.19
Offen:
$17.29
24-Stunden-Volumen:
503.39K
Relative Volume:
0.94
Marktkapitalisierung:
$455.11M
Einnahmen:
$157.75M
Nettoeinkommen (Verlust:
$-29.73M
KGV:
-14.45
EPS:
-1.16
Netto-Cashflow:
$-21.00M
1W Leistung:
-3.12%
1M Leistung:
+37.38%
6M Leistung:
+8.20%
1J Leistung:
-12.07%
1-Tages-Spanne:
$16.17
$17.43
1-Wochen-Bereich:
$16.17
$17.70
52-Wochen-Spanne:
$8.04
$25.88
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Firmenname
Arcturus Therapeutics Holdings Inc
Sektor
Branche
Telefon
(858) 900-2660
Adresse
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Vergleichen Sie ARCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
16.76 | 453.48M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-28 | Eingeleitet | BTIG Research | Buy |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-07-24 | Eingeleitet | William Blair | Outperform |
| 2023-05-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-11-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-11-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-08-10 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-05-11 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-01-31 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2021-06-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-02-17 | Herabstufung | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-29 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | Herabstufung | ROTH Capital | Buy → Sell |
| 2020-12-08 | Bestätigt | B. Riley Securities | Buy |
| 2020-12-07 | Bestätigt | B. Riley Securities | Buy |
| 2020-10-26 | Eingeleitet | Barclays | Overweight |
| 2020-10-06 | Eingeleitet | Citigroup | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-30 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-16 | Eingeleitet | Raymond James | Outperform |
| 2020-07-13 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-09 | Herabstufung | WBB Securities | Buy → Hold |
| 2020-02-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-07 | Eingeleitet | Guggenheim | Buy |
| 2020-02-06 | Eingeleitet | Guggenheim | Buy |
| 2019-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-09-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Arcturus Therapeutics Holdings Inc Aktie (ARCT) Neueste Nachrichten
Arcturus Therapeutics Holdings Inc. recovery potential after sell offWeekly Stock Analysis & Daily Price Action Insights - Newser
Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Support & Resistance & Weekly Momentum Picks - Newser
Can you recover from losses in Arcturus Therapeutics Holdings Inc.Gap Down & Daily Risk Controlled Trade Plans - Newser
Is a relief rally coming for Arcturus Therapeutics Holdings Inc. holdersDividend Hike & Weekly Momentum Picks - Newser
Volume spikes in Arcturus Therapeutics Holdings Inc. stock – what they meanNew Guidance & Verified Trade Idea Suggestions - Newser
Visual trend scoring systems applied to Arcturus Therapeutics Holdings Inc.2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
How institutional ownership impacts Arcturus Therapeutics Holdings Inc. stockRecession Risk & Low Risk Entry Point Tips - Newser
Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersEarnings Risk Summary & Stepwise Trade Signal Guides - khodrobank.com
Top chart patterns to watch in Arcturus Therapeutics Holdings Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
When is the best time to exit Arcturus Therapeutics Holdings Inc.Forecast Cut & AI Based Buy and Sell Signals - Newser
What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Year in Review & Technical Pattern Based Signals - khodrobank.com
Signal strength of Arcturus Therapeutics Holdings Inc. stock in tech scannersJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
How to integrate Arcturus Therapeutics Holdings Inc. into portfolio analysis toolsEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
How sentiment analysis helps forecast Arcturus Therapeutics Holdings Inc.Portfolio Update Report & Growth Oriented Trade Recommendations - Newser
Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - khodrobank.com
How to build a dashboard for Arcturus Therapeutics Holdings Inc. stockEarnings Miss & Long-Term Growth Stock Strategies - Newser
Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowJuly 2025 News Drivers & Community Consensus Stock Picks - khodrobank.com
Can Arcturus Therapeutics Holdings Inc. Escape Recent Bear Channel2025 Momentum Check & Pattern Based Trade Signal System - beatles.ru
Intraday pattern recognizer results for Arcturus Therapeutics Holdings Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
How to track smart money flows in Arcturus Therapeutics Holdings Inc.2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser
Real time alert setup for Arcturus Therapeutics Holdings Inc. performance2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2025 Earnings Call Transcript - MSN
US High Growth Tech Stocks To Watch Now - simplywall.st
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross? - Zacks Investment Research
Using data tools to time your Arcturus Therapeutics Holdings Inc. exit2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Automated trading signals detected on Arcturus Therapeutics Holdings Inc.July 2025 Recap & Capital Efficient Trade Techniques - Newser
Will Arcturus Therapeutics Holdings Inc. outperform the market2025 Key Lessons & Daily Technical Forecast Reports - Newser
Is Arcturus Therapeutics Holdings Inc. forming a reversal pattern2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
How to escape a deep drawdown in Arcturus Therapeutics Holdings Inc.2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Is Arcturus Therapeutics Holdings Inc. stock entering bullish territoryJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
How Arcturus Therapeutics Holdings Inc. stock performs during market volatilityJuly 2025 Earnings & Long-Term Safe Return Strategies - Newser
Arcturus Therapeutics’ Strategic Shift: Focusing on mRNA Therapeutics to Extend Cash Runway and Drive Long-Term Value - AInvest
Strategies to average down on Arcturus Therapeutics Holdings Inc.Weekly Market Outlook & Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-30 22:19:33 - Newser
Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):